A study to assess the safety, dose conversion and titration of Duragesic (fentanyl transdermal system) in pediatric subjects with chronic pain requiring opioid therapy.
Phase of Trial: Phase III
Latest Information Update: 12 May 2009
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 12 May 2009 Actual end date (Apr 2002) added as reported by ClinicalTrials.gov.
- 12 May 2009 Actual initiation date (Feb 2000) added as reported by ClinicalTrials.gov.
- 25 Nov 2006 New trial record.